Methylation in promoter regions of PITX2 and RASSF1A genes in association with clinicopathological features in breast cancer patients.
about
Genetic variation of long non-coding RNA TINCR contribute to the susceptibility and progression of colorectal cancerThe Predictive Value of PITX2 DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and Challenges.PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients.
P2860
Methylation in promoter regions of PITX2 and RASSF1A genes in association with clinicopathological features in breast cancer patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Methylation in promoter region ...... res in breast cancer patients.
@en
Methylation in promoter region ...... res in breast cancer patients.
@nl
type
label
Methylation in promoter region ...... res in breast cancer patients.
@en
Methylation in promoter region ...... res in breast cancer patients.
@nl
prefLabel
Methylation in promoter region ...... res in breast cancer patients.
@en
Methylation in promoter region ...... res in breast cancer patients.
@nl
P2093
P2860
P1433
P1476
Methylation in promoter region ...... res in breast cancer patients.
@en
P2093
Andrea Mendelova
Bibiana Malicherova
Eva Jezkova
Karol Dokus
Karol Kajo
Lukas Plank
Pavol Zubor
Zora Lasabova
P2860
P2888
P356
10.1007/S13277-016-5324-3
P577
2016-10-15T00:00:00Z